Low-dose glucocorticoid improves progression-free survival of children with B cell acute lymphoblastic leukaemia following chimeric antigen receptor T-cell therapy.

Front Immunol · 2025 · PMC12605194 · PMID 41235219

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Further analysis of the effect of immunosuppressant therapy on long-term prognoses showed a trend towards better outcomes in the GC group than in the non-GC group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.